Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

Price to Sales (P/S)
since 2012

Microsoft Excel

Calculation

AbbVie Inc., P/S, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of AbbVie Inc. Annual Report.


Share Price
The share price demonstrated significant volatility over the period analyzed. Starting at $38.50 in March 2013, it generally increased, reaching a notable peak at $118.60 in February 2018. Following this peak, there was a pronounced decline to $79.41 in February 2019. Subsequently, the share price exhibited a steady upward trajectory, culminating at $192.87 in February 2025, the highest value in the series.
Sales per Share
Sales per share showed a consistent and generally upward trend across the years. From $11.65 in March 2013, the metric increased steadily, reaching $32.81 in February 2023. A slight decline appeared in February 2024 to $30.75, but it rose again to $31.91 by February 2025. This pattern suggests growing sales performance with minor fluctuations.
Price-to-Sales (P/S) Ratio
The P/S ratio exhibited high variability during the period. It began at 3.30 in March 2013 and spiked sharply to 6.67 in February 2018, coinciding with the peak share price. This value then dropped to 3.58 by February 2019, reflecting the share price decline. Subsequently, the ratio gradually increased once more, reaching 6.04 in February 2025. The fluctuations in P/S indicate changing market valuations relative to sales, including periods of high investor optimism and corrections.
Overall Observations
The share price and P/S ratio show volatile behavior, marked by significant peaks and troughs, while sales per share demonstrate a stable growth trend. The disconnect between share price and sales at certain points, such as the 2018 peak in P/S ratio and share price, indicates varying market sentiment or external factors influencing valuation beyond fundamental sales growth.

Comparison to Competitors

AbbVie Inc., P/S, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).


Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

AbbVie Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).


Comparison to Industry (Health Care)

AbbVie Inc., P/S, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).